PMID- 16480519 OWN - NLM STAT- MEDLINE DCOM- 20060413 LR - 20181113 IS - 1471-2202 (Electronic) IS - 1471-2202 (Linking) VI - 7 DP - 2006 Feb 16 TI - Electrocortical effects of MDMA are potentiated by acoustic stimulation in rats. PG - 13 AB - BACKGROUND: 3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) is known for its toxicological, psychopathological and abuse potential. Some environmental conditions, e.g. acoustic stimulation typical of the "rave scene" can influence the toxicity of this drug. RESULTS: We investigated the effects of low doses of MDMA in vivo using Wistar rats in the absence of acoustic stimulation (white noise; 95 Db) demonstrating that ecstasy is able to induce a significant activation (reduction of Electrocortical total power) of the telencephalic cortex that spontaneously reverts in the absence of sensorial stimuli, whereas it persists for several days if, in addition to MDMA, the animals are exposed to acoustic stimulation. CONCLUSION: Our data demonstrate that low doses of MDMA are able to reduce electrocortical total power, and that this effect is potentiated by sensorial stimuli commonly present in certain environments, such as rave parties. FAU - Iannone, Michelangelo AU - Iannone M AD - Section of Pharmacology, CNR-Institute of Neurological Science, Roccelletta di Borgia, Catanzaro, Italy. m.iannone@isn.cnr.it FAU - Bulotta, Stefania AU - Bulotta S FAU - Paolino, Donatella AU - Paolino D FAU - Zito, Maria Cristina AU - Zito MC FAU - Gratteri, Santo AU - Gratteri S FAU - Costanzo, Francesco S AU - Costanzo FS FAU - Rotiroti, Domenicantonio AU - Rotiroti D LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060216 PL - England TA - BMC Neurosci JT - BMC neuroscience JID - 100966986 RN - 0 (Hallucinogens) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - *Acoustic Stimulation/methods MH - Animals MH - Cerebral Cortex/*drug effects/radiation effects MH - Dose-Response Relationship, Drug MH - Electroencephalography/methods MH - Hallucinogens/*pharmacology MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology MH - Rats MH - Spectrum Analysis MH - Time Factors PMC - PMC1386694 EDAT- 2006/02/17 09:00 MHDA- 2006/04/14 09:00 PMCR- 2006/02/16 CRDT- 2006/02/17 09:00 PHST- 2005/07/28 00:00 [received] PHST- 2006/02/16 00:00 [accepted] PHST- 2006/02/17 09:00 [pubmed] PHST- 2006/04/14 09:00 [medline] PHST- 2006/02/17 09:00 [entrez] PHST- 2006/02/16 00:00 [pmc-release] AID - 1471-2202-7-13 [pii] AID - 10.1186/1471-2202-7-13 [doi] PST - epublish SO - BMC Neurosci. 2006 Feb 16;7:13. doi: 10.1186/1471-2202-7-13.